These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 34210107)

  • 1. Molecular and Circulating Biomarkers of Brain Tumors.
    Jelski W; Mroczko B
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34210107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Molecular Markers in Glioblastoma-Benefits of Liquid Biopsy.
    Birkó Z; Nagy B; Klekner Á; Virga J
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053907
    [No Abstract]   [Full Text] [Related]  

  • 4. Liquid biopsy for brain tumors.
    Shankar GM; Balaj L; Stott SL; Nahed B; Carter BS
    Expert Rev Mol Diagn; 2017 Oct; 17(10):943-947. PubMed ID: 28875730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating biomarkers in patients with glioblastoma.
    Müller Bark J; Kulasinghe A; Chua B; Day BW; Punyadeera C
    Br J Cancer; 2020 Feb; 122(3):295-305. PubMed ID: 31666668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Liquid Biopsies in Pediatric Brain Tumors.
    Tang K; Gardner S; Snuderl M
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):934-940. PubMed ID: 32766689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging circulating biomarkers in glioblastoma: promises and challenges.
    Touat M; Duran-Peña A; Alentorn A; Lacroix L; Massard C; Idbaih A
    Expert Rev Mol Diagn; 2015; 15(10):1311-23. PubMed ID: 26394701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of glioblastoma in biofluids.
    Figueroa JM; Carter BS
    J Neurosurg; 2018 Aug; 129(2):334-340. PubMed ID: 29053069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system.
    Le Rhun E; Seoane J; Salzet M; Soffietti R; Weller M
    Cancer Lett; 2020 Jun; 480():24-28. PubMed ID: 32229189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas.
    Yekula A; Muralidharan K; Rosh ZS; Youngkin AE; Kang KM; Balaj L; Carter BS
    Adv Biosyst; 2020 Dec; 4(12):e2000029. PubMed ID: 32484293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy in CNS tumors: Current status & future perspectives.
    Husain N; Husain A; Mishra S; Srivastava P
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!
    Fontanilles M; Duran-Peña A; Idbaih A
    Curr Neurol Neurosci Rep; 2018 Mar; 18(3):13. PubMed ID: 29520561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
    Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
    Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools.
    Cela I; Capone E; Trevisi G; Sala G
    Semin Cancer Biol; 2024 Jun; 101():25-43. PubMed ID: 38754752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients.
    Ricklefs FL; Wollmann K; Salviano-Silva A; Drexler R; Maire CL; Kaul MG; Reimer R; Schüller U; Heinemann S; Kolbe K; Mummert T; Glatzel M; Peine S; Gempt J; Westphal M; Dührsen L; Lamszus K
    Neuro Oncol; 2024 Jul; 26(7):1280-1291. PubMed ID: 38567448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.
    Wu J; Hu S; Zhang L; Xin J; Sun C; Wang L; Ding K; Wang B
    Theranostics; 2020; 10(10):4544-4556. PubMed ID: 32292514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Functionalized Superlattice Nanosensor Enables Glioblastoma Diagnosis Using Liquid Biopsy.
    Premachandran S; Haldavnekar R; Ganesh S; Das S; Venkatakrishnan K; Tan B
    ACS Nano; 2023 Oct; 17(20):19832-19852. PubMed ID: 37824714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications.
    Boire A; Brandsma D; Brastianos PK; Le Rhun E; Ahluwalia M; Junck L; Glantz M; Groves MD; Lee EQ; Lin N; Raizer J; Rudà R; Weller M; Van den Bent MJ; Vogelbaum MA; Chang S; Wen PY; Soffietti R
    Neuro Oncol; 2019 May; 21(5):571-584. PubMed ID: 30668804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
    Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
    Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.